-
Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR, 1999: Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism[J]. Mol Cell Biol, 19, 4592-4599. doi: 10.1128/MCB.19.7.4592
-
Carvalho M, Derse D, 1991: Mutational analysis of the equine infectious anemia virus Tat-responsive element[J]. J Virol, 65, 3468-3474.
-
Cook RF, Leroux C, Cook SJ, Berger SL, Lichtenstein DL, Ghabrial NN, Montelaro RC, Issel CJ, 1998: Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus[J]. J Virol, 72, 1383-1393.
-
Cook RF, Leroux C, Issel CJ, 2013: Equine infectious anemia and equine infectious anemia virus in 2013: a review[J]. Vet Microbiol, 167, 181-204. doi: 10.1016/j.vetmic.2013.09.031
-
Craigo JK, Montelaro RC, 2013: Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity[J]. Viruses, 5, 2963-2976. doi: 10.3390/v5122963
-
Du C, Ma J, Liu Q, Li YF, He XJ, Lin YZ, Wang XF, Meng QW, Wang X, Zhou JH, 2015: Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection[J]. Retrovirology, 12, 36-. doi: 10.1186/s12977-015-0163-7
-
Frech K, Brack-Werner R, Werner T, 1996: Common modular structure of lentivirus LTRs[J]. Virology, 224, 256-267. doi: 10.1006/viro.1996.0527
-
He X, Shao YM, Xue F, Fan XJ, Shen RX, 2003: Construction of infectious chimeric clones of equine infectious anemia virus (EIAV)[J]. Chin J Virol, 19, 128-132.
-
Jiang CG, Gao X, Ma J, Lin YZ, Wang XF, Zhao LP, Hua YP, Liu D, Zhou JH, 2011: C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity[J]. Virus Res, 158, 235-245. doi: 10.1016/j.virusres.2011.04.007
-
Ma J, Wang SS, Lin YZ, Liu HF, Wei HM, Du C, Wang XF, Zhou JH, 2013: An attenuated EIAV strain and its molecular clone strain differentially induce the expression of Toll-like receptors and type-I interferons in equine monocyte-derived macrophages[J]. Vet Microbiol, 166, 263-269. doi: 10.1016/j.vetmic.2013.06.005
-
Shen T, Liang H, Tong X, Fan X, He X, Ma Y, Xiang W, Shen R, Zhang X, Shao Y, 2006: Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence[J]. Vaccine, 24, 738-749. doi: 10.1016/j.vaccine.2005.08.084
-
Wang XF, Lin YZ, Li Q, Liu Q, Zhao WW, Du C, Chen J, Wang X, Zhou JH, 2016: Genetic evolution during the development of an attenuated EIAV vaccine[J]. Retrovirology, 13, 9-. doi: 10.1186/s12977-016-0240-6
-
Wang XF, Liu Q, Wang YH, Wang S, Chen J, Lin YZ, Ma J, Zhou JH, Wang X, 2018: Characterization of equine infectious anemia virus long terminal repeat quasispecies in vitro and in vivo[J]. J Virol, 92, e02117-e02150.
-
Yin X, Hu Z, Gu Q, Wu X, Zheng YH, Wei P, Wang X, 2014: Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein[J]. J Virol, 88, 1259-1270. doi: 10.1128/JVI.03148-13